Optomed Oyj (OPTOMED.HE)
EUR 3.95
(3.27%)
EUR 3.95
(3.27%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 15.1 Million EUR | 3.0% |
| 2022 | 14.66 Million EUR | -1.28% |
| 2021 | 14.85 Million EUR | 14.13% |
| 2020 | 13.01 Million EUR | -13.13% |
| 2019 | 14.97 Million EUR | 3.55% |
| 2018 | 14.46 Million EUR | 109.64% |
| 2017 | 6.89 Million EUR | 4.39% |
| 2016 | 6.6 Million EUR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 3.32 Million EUR | -9.1% |
| 2024 Q2 | 3.5 Million EUR | 5.35% |
| 2023 Q2 | 3.74 Million EUR | 7.65% |
| 2023 FY | 15.1 Million EUR | 3.0% |
| 2023 Q4 | 3.66 Million EUR | -13.23% |
| 2023 Q3 | 4.21 Million EUR | 12.66% |
| 2023 Q1 | 3.47 Million EUR | -13.33% |
| 2022 Q3 | 3.7 Million EUR | -0.88% |
| 2022 Q4 | 4.01 Million EUR | 8.46% |
| 2022 Q2 | 3.73 Million EUR | 16.15% |
| 2022 Q1 | 3.21 Million EUR | -9.52% |
| 2022 FY | 14.66 Million EUR | -1.28% |
| 2021 FY | 14.85 Million EUR | 14.13% |
| 2021 Q1 | 3.94 Million EUR | -2.4% |
| 2021 Q2 | 4.01 Million EUR | 1.72% |
| 2021 Q4 | 3.55 Million EUR | 6.28% |
| 2021 Q3 | 3.34 Million EUR | -16.7% |
| 2020 Q4 | 4.04 Million EUR | 21.06% |
| 2020 Q2 | 2.59 Million EUR | -14.4% |
| 2020 Q3 | 3.33 Million EUR | 28.53% |
| 2020 FY | 13.01 Million EUR | -13.13% |
| 2020 Q1 | 3.03 Million EUR | -29.91% |
| 2019 Q3 | 3.55 Million EUR | -7.96% |
| 2019 FY | 14.97 Million EUR | 3.55% |
| 2019 Q4 | 4.32 Million EUR | 21.91% |
| 2019 Q1 | 3.24 Million EUR | -30.89% |
| 2019 Q2 | 3.85 Million EUR | 19.07% |
| 2018 Q3 | 3.36 Million EUR | 0.0% |
| 2018 Q4 | 4.68 Million EUR | 39.44% |
| 2018 FY | 14.46 Million EUR | 109.64% |
| 2017 FY | 6.89 Million EUR | 4.39% |
| 2016 FY | 6.6 Million EUR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|